FDA Approved: TACROLIMUS — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved a Tacrolimus generic from Biocon Pharma Inc. (ANDA212297) for immunosuppression to prevent organ transplant rejection in kidney, liver, and heart t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

ORIG AP for TACROLIMUS (TACROLIMUS)